PACS Group has agreed to acquire the operations of 34 skilled nursing facilities from Eduro Healthcare, adding 3,633 beds across Texas, Montana, New Mexico, North Dakota, South Dakota, and Utah. Most of the portfolio is in Texas, with 22 facilities, and the transaction is expected to close in multiple tranches, with the bulk targeted for the third quarter of 2026 pending regulatory approvals.
For PACS, this is a scale deal with a geographic twist. The company already operates more than 320 post-acute and senior living facilities across 17 states. Eduro gives it immediate density in Texas and entry into four new states, extending a regional operating model that depends on local leadership, centralized support, and enough bed count to spread compliance, staffing, and procurement costs over a larger base.
That matters in skilled nursing, where operators are still navigating labor inflation, uneven Medicaid reimbursement, and rising scrutiny around quality metrics. Buying a functioning portfolio with established teams is faster and often less risky than building market presence one facility at a time. Eduro’s own comments suggest another familiar dynamic in healthcare services M&A: founder succession. Family-owned operators that have improved clinical and financial performance are increasingly choosing to sell into larger platforms rather than absorb the next cycle of reimbursement and regulatory pressure alone.
PACS is also buying optionality. A six-state portfolio creates more leverage with referral sources, managed care counterparties, and vendors. It also gives the company a broader base from which to shift resources as state-level reimbursement and labor conditions change. In post-acute care, that flexibility can be as valuable as headline growth.
The timing fits a market that remains active despite softer volumes. Acquire.fyi data shows health sector deal value has reached $76.8 billion year to date, up 91.8% from a year earlier, even as volume is down 4%, a sign that buyers are concentrating capital behind larger, more consequential assets. PACS is not writing an eye-catching megadeal check here. It is doing something more typical of this cycle: consolidating a fragmented care segment where operational discipline, not financial engineering, will decide whether scale translates into margin.
Source: Company press release and Acquire.fyi's proprietary data
